Clinical Courses of Two Pediatric Patients with Acute Megakaryoblastic Leukemia Harboring the CBFA2T3-GLIS2 Fusion Gene
Journal Title: Turkish Journal of Hematology - Year 2016, Vol 33, Issue 4
Abstract
Acute megakaryoblastic leukemia (AMKL) in children without Down syndrome (DS) has an extremely poor outcome with 3-year survival of less than 40%, whereas AMKL in children with DS has an excellent survival rate. Recently, a novel recurrent translocation involving CBFA2T3 and GLIS2 was identified in about 30% of children with non-DS AMKL, and the fusion gene was reported as a strong poor prognostic factor in pediatric AMKL. We report the difficult clinical courses of pediatric patients with AMKL harboring the CBFA2T3-GLIS2 fusion gene.
Authors and Affiliations
Mayu Ishibashi, Tomoko Yokosuka, Masakatsu D. Yanagimach, Fuminori Iwasaki, Shin-ichi Tsujimoto, Koji Sasaki, Masanobu Takeuchi, Reo Tanoshima, Hiromi Kato, Ryosuke Kajiwara, Fumiko Tanaka, Hiroaki Goto, Shumpei Yokota
Keywords
Related Articles
- EP ID EP228566
- DOI 10.4274/tjh.2016.0008
- Views 101
- Downloads 0
Clinical Trials in Turkey
Turkey is an emerging economy in almost all sectors, and especially in pharmaceuticals. Turkey has had clinical trial legislation for a long time. There are also clinical trial regulations and guidelines. Turkey has take...
Cilt Nodülleri ve Karın İçi Kitle ile Başvuran Lösemik Olmayan Granülositik Sarkomlu Olgu
Akım Sitometrisi: Patolojik Tanıda Hızlı ve Sağlam Adjuvan Bir Teknik
Erişkin T-hücreli Lösemi/Lenfomalı Hemodiyaliz Hastasında Mogamulizumab Tedavisi
Influenza A Infection and Stem Cell Mobilization
.